Results 171 to 180 of about 7,520 (210)

Alpha-adrenergic antagonists and iris dynamics: Challenges and solutions in cataract surgery. [PDF]

BMC Ophthalmol
Kaushik J, Sharma R, Goyal S, Dangi M, Jha RK, Singh A.   +5 more
europepmc   +1 more source

Predictors and associations of complications in ureteroscopy for stone disease using AI: outcomes from the FLEXOR registry. [PDF]

Urolithiasis
Nedbal C, Gauhar V, Adithya S, Tramanzoli P, Naik N, Gite S, Sevalia H, Castellani D, Panthier F, Teoh JYC, Chew BH, Fong KY, Boulmani M, Gadzhiev N, Herrmann TRW, Traxer O, Somani BK.   +16 more
europepmc   +1 more source

Evaluation of the Effect of an α-Adrenergic Blocker, a PPAR-γ Receptor Agonist, and a Glycemic Regulator on Chronic Kidney Disease in Diabetic Rats. [PDF]

Int J Mol Sci
Morones J, Pérez M, Muñoz M, Sánchez E, Ávila M, Topete J, Ventura J, Martínez S.   +7 more
europepmc   +1 more source

Benign Prostatic Hyperplasia and Sexual Dysfunction: Review of the Impact of New Medical and Surgical Therapies on Sexual Health. [PDF]

Curr Urol Rep
Singh D, Nguyen T, Burnam P, Greenberg J, Raheem O, Hellstrom W.   +5 more
europepmc   +1 more source

Effects of Alpha-Lytic Therapy Withdrawal on Choroidal Parameters in Intraoperative Floppy Iris Syndrome High-Risk Patients. [PDF]

J Clin Med
Gioia M, De Bernardo M, De Luca M, Rosa N.   +3 more
europepmc   +1 more source

Efficacy and Safety of Boldine Combined with Phyllanthus niruri and Ononis spinosa in Medical Expulsive Therapy for Distal Ureteral Stones with Renal Colic: A Single-Center, Retrospective Cohort Study. [PDF]

Medicina (Kaunas)
Di Mauro E, Saldutto P, La Rocca R, Sangiorgi G, Patelli G, Barone B, Verratti V, Castellucci R, Napolitano L, Iacono F, Altieri VM.   +10 more
europepmc   +1 more source

Tamsulosin: Ureteral Stones [PDF]

Hospital Pharmacy, 2005
Off-Label Drug Uses This Hospital Pharmacy feature is extracted from Off-Label DrugFacts, a quarterly publication available from Facts and Comparisons. Off-Label DrugFacts is a practitioner-oriented resource for information about specific FDA-unapproved drug uses.
Joyce A. Generali, Dennis J. Cada
openaire   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Tamsulosin: an overview

World Journal of Urology, 2002
This article reviews the contemporary literature related to tamsulosin, which is now the most widely used alpha antagonist in treating benign prostatic hyperplasia. The primary emphasis of this article is on the clinical data that exist related to this agent.
Karl-Erik Andersson, Christopher R. Chapple   +1 more
openaire   +3 more sources

Voltammetric investigation of Tamsulosin

Talanta, 2003
The electrooxidative behavior and determination of Tamsulosin HCl (TAM), one of the alpha(1)-adrenoceptor antagonist, on a glassy carbon disc electrode were investigated for the first time by using cyclic, linear sweep, differential pulse (DPV) and square wave voltammetry (SWV). TAM showed an irreversible oxidation behavior at all pH values and buffers
Bengi Uslu, Hassan Y. Aboul-Enein, Sibel A. Ozkan   +2 more
openaire   +3 more sources